ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27 | -93.1% | 4,711 | +375.4% | 0.00% | 0.0% |
| Q4 2022 | $393 | -99.9% | 991 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $388,000 | +19.0% | 1,016 | +16.2% | 0.00% | 0.0% |
| Q2 2022 | $326,000 | +22.1% | 874 | +5.0% | 0.00% | +50.0% |
| Q1 2022 | $267,000 | +23.0% | 832 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $217,000 | -17.2% | 835 | -6.7% | 0.00% | 0.0% |
| Q3 2021 | $262,000 | -70.5% | 895 | -69.1% | 0.00% | -60.0% |
| Q2 2021 | $889,000 | +4.3% | 2,894 | +0.6% | 0.01% | 0.0% |
| Q1 2021 | $852,000 | +7.6% | 2,876 | +12.9% | 0.01% | 0.0% |
| Q4 2020 | $792,000 | +30.9% | 2,547 | +5.4% | 0.01% | +25.0% |
| Q3 2020 | $605,000 | +5.2% | 2,416 | +9.0% | 0.00% | 0.0% |
| Q2 2020 | $575,000 | +86.7% | 2,216 | +5.2% | 0.00% | +33.3% |
| Q1 2020 | $308,000 | – | 2,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |